CLINICAL TRIAL: PHASE I/II MULTICENTER,OPEN LABEL,NONCOMPARITIVE STUDY OF HIV AF

临床试验：I/II 期多中心、开放标签、HIV AF 非比较研究

• 批准号: 7950832
• 负责人: Sharon A Nachman
• 金额: $ 1.92万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7950832
• 关键词: Adolescent; Child; Clinical Research; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; HIV; Institution; Phase; Research; Research Personnel; Resources; Safety; Source; Staging; United States National Institutes of Health; age group; open label

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. 1. In Stage I, to evaluate the short term safety and tolerability of raltegravir, in HIV infected children and adolescents, added to an initial stable background therapy* which will then be optimized in children and adolescents in the age groups of =2 to <6, =6 to <12 and =12 to <19 years.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 1. 在第I阶段，评估雷特格韦在HIV感染儿童和青少年中的短期安全性和耐受性，将其添加到初始稳定背景治疗 * 中，然后在年龄组=2至<6岁，=6至<12岁和=12至<19岁的儿童和青少年中进行优化。